Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis

Abstract

Background

Epidemiologic studies have shown a positive correlation of multiple sclerosis (MS) prevalence with latitude. However, there has not been a causal association found. Increased dietary intake and increased serum levels of vitamin D showed to be protective for the development of MS. Ultraviolet (UV) radiation plays an important role in vitamin D synthesis and could potentially explain both latitude differences in MS prevalence and the low levels of vitamin D in individuals with MS.

Objective

To evaluate the relationship between UV radiation and MS prevalence using geospatial analysis.

Methods

Geospatial analysis was performed on North American regions and separately for the continental United States. The correlation of UV radiation (measured as UV index [UVI]) versus MS prevalence and UV radiation versus case-control ratios was calculated. In addition, the relative risk (RR) of MS was determined for regions/states with low UV radiation exposure.

Results

Case-control ratios by US state and MS prevalence by North American region showed a strong negative (inverse) correlation with UVI (R = −0.72 and −0.86, respectively). The RR for the five highest risk states/lowest UVI versus the five lowest risk states/highest UVI was increased (RR = 1.8–5.4). The RR for MS, when comparing North American regions with lowest and highest UVI, was 3.78 and within US regions was 1.52.

Conclusion

This analysis suggests a strong association between UV radiation and MS distribution, and an increase in risk for MS in those areas with a low UVI.

Keywords

epidemiology geography multiple sclerosis prevalence ultraviolet rays sunlight vitamin D

Get full access to this article

View all access options for this article.

References

1 Kantarci OH . Genetics and natural history of multiple sclerosis. Semin Neurol 2008; 28: 7–16.

2 Koch-Henriksen N . The Danish Multiple Sclerosis Registry: a 50-year follow-up. Mult Scler 1999; 5: 293–296.

3 Franklin GM Nelson L . Environmental risk factors in multiple sclerosis: causes, triggers, and patient autonomy. Neurology 2003; 61: 1032–1034.

4 Kurtzke JF Beebe GW Norman JE . Epidemiology of multiple sclerosis in US veterans: III. Migration and the risk of MS. Neurology 1985; 35: 672–678.

5 McLeod JG Hammond SR Hallpike JF . Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results. Med J Aust 1994; 160: 117–122.

6 Hernan MA Olek MJ Ascherio A . Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999; 53: 1711–1718.

7 McMichael AJ Hall AJ . Does immunosuppressive ultraviolet radiation explain the latitude gradient for multiple sclerosis? Epidemiology 1997; 8: 642–645.

8 Shatin R . Multiple sclerosis and geography. New interpretation of epidemiological observations. Neurology 1964; 14: 338–344.

9 Freedman DM Dosemeci M Alavanja MC . Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 2000; 57: 418–421.

10.

10 Kampman MT Wilsgaard T Mellgren SI . Outdoor activities and diet in childhood and adolescence relate to MS risk above the Arctic Circle. J Neurol 2007; 254: 471–477.

11.

11 Munger KL Zhang SM O’Reilly E . Vitamin D intake and incidence of multiple sclerosis. Neurology 2004; 62: 60–65.

12.

12 Munger KL Levin LI Hollis BW Howard NS Ascherio A . Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832–2838.

13.

13 Lips P . Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4–8.

14.

14 White JH . Vitamin D signaling, infectious diseases and regulation of innate immunity. Infect Immun 2008; 76: 3837–3843.

15.

15 Holick MF . Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61(Suppl. 3): 638S–645S.

16.

16 Turnbull DJ Parisi AV . Optimizing solar UV-radiation exposures for vitamin D3: comparing global and diffuse spectral UV radiation. Radiat Res 2008; 169: 344–349.

17.

17 Hanneman KK Cooper KD Baron ED . Ultraviolet immunosuppression: mechanisms and consequences. Dermatol Clin 2006; 24: 19–25.

18.

18 Noonan FP Bucana C Sauder DN De Fabo EC . Mechanism of systemic immune suppression by UV irradiation in vivo. II. The UV effects on number and morphology of epidermal Langerhans cells and the UV-induced suppression of contact hypersensitivity have different wavelength dependencies. J Immunol 1984; 132: 2408–2416.

19.

19 Kripke ML . Ultraviolet radiation and immunology: something new under the sun–presidential address. Cancer Res 1994; 54: 6102–6105.

20.

20 Beck CA Metz LM Svenson LW Patten SB . Regional variation of multiple sclerosis prevalence in Canada. Mult Scler 2005; 11: 516–519.

21.

21 Noonan CW Kathman SJ White MC . Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002; 58: 136–138.

22.

22 Kurtzke JF Beebe GW Norman JE . Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution. Neurology 1979; 29: 1228–1235.

23.

23 Lauer K . The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor – analytic study. J Clin Epidemiol 1994; 47: 43–48.

24.

25.

26.

27.

27 McKenzie R Smale D Kotkamp M . Relationship between UVB and erythemally weighted radiation. Photochem Photobiol Sci 2004; 3: 252–256.

28.

28 van der Mei IA Ponsonby AL Blizzard L Dwyer T . Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001; 20: 168–174.

29.

29 Sloka JS Pryse-Phillips WE Stefanelli M . The relation of ultraviolet radiation and multiple sclerosis in Newfoundland. Can J Neurol Sci 2008; 35: 69–74.

30.

30 Ebers GC . Environmental factors and multiple sclerosis. Lancet Neurol 2008; 7: 268–277. Temporal trends in the incidence of multiple sclerosis. Neurology 2008; 71: 129–135.

31.

31 Vukusic S Van Bockstael V Gosselin S Confavreux C . Regional variations in the prevalence of multiple sclerosis in French farmers. J Neurol Neurosurg Psychiatry 2007; 78: 707–709.

32.

32 Gale CR Martyn CN . Migrant studies in multiple sclerosis. Prog Neurobiol 1995; 47: 425–448.

33.

33 Szodoray P Nakken B Gaal J . The complex role of vitamin D in autoimmune diseases. Scand J Immunol 2008; 68: 261–269.

34.

34 Fioletov VE Kerr JB McArthur LJB Wardle DI Mathews TW . Estimating UV index climatology over Canada. J Appl Meteorol 2003; 42: 417–433.

35.

35 Warren SA Svenson LW Warren KG . Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada. Mult Scler 2008; 14: 872–879.

36.

36 Alonso A Hernán M . Temporal trends in the incidence of multiple sclerosis. Neurology 2008; 71: 129–135.

37.

37 Orton SM Herrera BM Yee IM Valdar W Ramagopalan SV Sadovnick AD . Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 2006; 5: 932–936.

38.

38 Sweeney VP Sadovnick AD Brandejs V . Prevalence of multiple sclerosis in British Columbia. Can J Neurol Sci 1986; 13: 47–51.

39.

39 Hader WJ Elliot M Ebers GC . Epidemiology of multiple sclerosis in London and Middlesex County, Ontario, Canada. Neurology 1988; 38: 617–621.

40.

40 Sloka JS Pryse-Phyllips WEM Stefanelli M . Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador. Can J Neurol Sci 2005; 32: 37–42.

41.

41 Hader WJ Yee IML . Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan. Neurology 2007; 69: 1224–1229.

42.

42 Lauer K . Ecologic studies in multiple sclerosis. Neurology 1997; 49: S18–S26.

43.

43 Liou KN . An introduction to atmospheric radiation. International geophysics series, vol. 84. San Diego: Academic Press; 2002. p. 50–52.

44.

45.

45 Hammond SR English DR McLeod JG . The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia. Brain 2000; 123: 968–974.